Indexed in Journament

Open forum infectious diseases

ISSN 2328-8957· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
44.7/100
Journament Score
#236
Journament Rank
185
Articles Indexed

About This Journal

Short Name Open Forum Infect Dis
Abbreviated Name open forum infectious diseases
ISSN 2328-8957
URL https://academic.oup.com/ofid

Indexings

scopus ncbi ulakbim sci

Tools & Certificate of Indexing

Certificate of Indexing
Quality Badge Widget - Embed on Your Website

Display your journal's verified indexing scores on your website with our self-contained widget.

One-Line JavaScript Embed:
Advantages: Single-line script, seamless DOM integration, clickable badges linking to full journal profile.
Standard iFrame Embed Code:
Widget Preview:

Publications Per Year

Articles (185)

2019
Histoplasmosis, An Underdiagnosed Disease Affecting People Living with HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection
Falci, D.
Vol. 6 , pp. 0-0
447 views DOI
2020
Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy.
Schulte, Benjamin;Wübbolding, Maximilian;Marra, Fiona;Port, Kerstin;Manns, Michael P;Back, David;Cornberg, Markus;Stichtenoth, Dirk O;Höner Zu Siederdissen, Christoph;Maasoumy, Benjamin;
Vol. 7 , No. 2 , pp. ofaa040
443 views DOI Abstract
2018
"One of the Funniest People in America" describes his bout with a life-threatening infection: Dr. Paul Sax interviews comedy writer Andy Borowitz.
Vol. 5 , No. 4 , pp. ofy071
435 views DOI
2019
Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial.
Petchkum, Porkaew;Sungkanuparph, Somnuek;Kiertiburanakul, Sasisopin;Phuphuakrat, Angsana;
Vol. 6 , No. 4 , pp. ofz155
417 views DOI Abstract
2020
Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature.
Zingg, Sandra;Nicoletti, G Jacopo;Kuster, Sabine;Junker, Milena;Widmer, Andreas;Egli, Adrian;Hinic, Vladimira;Sendi, Parham;Battegay, Manuel;Bättig, Veronika;Khanna, Nina;Tschudin-Sutter, Sarah;
Vol. 7 , No. 6 , pp. ofaa185
395 views DOI Abstract
2019
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2017.
Chastain, Daniel B;Cluck, David B;Stover, Kayla R;Lusardi, Katherine T;Marx, Ashley;Green, Sarah;Faulkner-Fennell, Carmen;Turner, Michelle;Chahine, Elias B;Bookstaver, P Brandon;Bland, Christopher M;
Vol. 6 , No. 4 , pp. ofz133
394 views DOI Abstract
2019
Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial.
Wiriyatanakorn, Sirichai;Sungkanuparph, Somnuek;
Vol. 6 , No. 7 , pp. ofz297
380 views DOI Abstract
2020
Disseminated Masquerading as Pulmonary Tuberculosis in a Patient With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome.
Bertrán-López, Jovanna;Abbott, Andrew;Archibald, Lennox K;Benninger, Lauryn;Lascano, Jorge;Kalyatanda, Gautam;
Vol. 7 , No. 6 , pp. ofaa186
373 views DOI Abstract
2020
Impact of Mandatory Infectious Diseases Consultation and Real-time Antimicrobial Stewardship Pharmacist Intervention on Bacteremia Bundle Adherence.
Arensman, Kellie;Dela-Pena, Jennifer;Miller, Jessica L;LaChance, Erik;Beganovic, Maya;Anderson, Morgan;Rivelli, Anne;Wieczorkiewicz, Sarah M;
Vol. 7 , No. 6 , pp. ofaa184
360 views DOI Abstract
2019
Mandatory flu vaccine for healthcare workers: Not Worthwhile
Edmond, M.
Vol. 6 , pp. 0-0
339 views DOI
2026
Impact of changes in chlamydia treatment guidelines on recurrent/persistent rectal <i>Chlamydia trachomatis</i> infections
Mary Bridget Waters, Anjuli D Wagner, Tim W. Menza, Anna Berzkalns, Lisa E. Manhart, Christine M Khosropour
DOI Abstract
2026
Metformin and weight changes in non-diabetic older people with HIV (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial
Cristina Marcelo, Andrés Esteban-Cantos, Francisco Jurado, Rocío Montejano, Lucía Gutiérrez-García, Alejandro de Gea-Grela, Patricia Martínez-Martín, Alejandro Vidal, Rosa de Miguel Buckley, Carlos M Oñoro-López, J González, Luz Martín‐Carbonero, José Ignacio Bernardino, Rocío Menéndez Colino, Noemí González Pérez de Villar, Berta Rodés, José Ramón Arribas
DOI Abstract
2026
Bacterial carriage and invasive infections among people who inject drugs: clinical and molecular epidemiology in an Australian prospective cohort
Lucy O. Attwood, Daniel O’Keefe, Jessica A. Wisniewski, Nhu Quynh Doan, Bek Petrovic, Mariel Beiers, Olga Vujovic, Stephanie J. Curtis, Peter Higgs, Jane Hawkey, Joseph Doyle, Trisha Peel, Anton Y. Peleg, Paul Dietze, Andrew J. Stewardson
DOI Abstract
2026
Similar Efficacy, Safety, and Immune Improvement Through 96 Weeks in Individuals With Limited HIV-1 Treatment Options Using Twice-Daily Dolutegravir- or Fostemsavir-Based Regimens
Antonella Castagna, Iacopo Marcon, Fangfang Du, Bo Li, Marcia Wang, Andrew L. Clark, Cynthia Donovan, Bryn Jones, Manyu Prakash
DOI Abstract
2026
Population HIV Viremia and Epidemic Transition: Findings from Sequential Surveys in Six sub-Saharan African Countries
Mansour Farahani, Suzue Saito, Shannon M. Farley, T Smart, Giles Reid, Wilford Kirungi, Owen Mugurungi, Rose Nyirenda, Wafaa El‐Sadr
DOI Abstract
2026
Identification of invasive aspergillosis in electronic health records
Emily Rayens, Jessica Skela, Bradley K. Ackerson, Magdalena E Pomichowski, Lance B. Price, Sara Y. Tartof
DOI Abstract
2026
Ongoing Outbreak of <i>Neisseria meningitidis</i> serogroup B in Pará State, Brazilian Amazon Region, following the COVID-19 pandemic
Diana da Costa Lobato, Ângela Cristina dos Reis Maia de Souza, Caroline Gava, Camilla de Miranda Ribeiro, Raissa dos Santos Calado Sampaio de Alencar, Greice Madeleine Ikeda do Carmo, Rosa Márcia Saraiva Gentil, Susan Beatriz Batista de Oliveira, Carlos Henrique Camargo, Cláudio Tavares Sacchi, Karoline Rodrigues Campos, Maria Eduarda de Araújo Morais, Gabriela Andrade Carvalho, Adrianne da Silva Zifirino, Ana Paula Silva de Lemos, Danielle Melo Sardinha, Karla Valéria Batista Lima
DOI Abstract
2026
Implementation of a Best Practice Advisory-Based HIV Screening Program in the Emergency Department with Integrated Infectious Diseases: A Descriptive Study
Brianna Hohmann, Madison Patrus, Smitha Gudipati, Thomas K. Hagerman, Nicholas Yared, Dalton Bender, Shannon Payne, Jun Jin, Jacob Manteuffel, Indira Brar
DOI Abstract
2026
Switching to Integrase Inhibitors and Cardiovascular Disease Risk in Treatment-Experienced People with HIV: A Sequential Target Trial Emulation in the Swiss HIV Cohort Study
Tristan Lee, Matthias Cavassini, Annalisa Marinosci, David Haerry, Marcel Stoeckle, Patrick Schmid, Luigia Elzi, Christoph A Fux, Philip Tarr, Lukas Baumann, Huldrych F. Günthard, Gilles Wandeler, Niklaus Daniel Labhardt, Bernard Surial, Frédérique Chammartin, The Swiss HIV Cohort Study, I A Abela, K Aebi-Popp, A Anagnostopoulos, E Bernasconi, D L Braun, H C Bucher, A Calmy, M Cavassini, A Ciuffi, G Dollenmaier, M Egger, L Elzi, J S Fehr, J Fellay, S Frigerio Malossa, C A Fux, H F Günthard, A Hachfeld, D H U Haerry, B Hasse, H H Hirsch, M Hoffmann, I Hösli, M Huber, D Jackson-Perry, C R Kahlert, D Kaufmann, O Keiser, T Klimkait, R D Kouyos, H Kovari, K Kusejko, N D Labhardt, K Leuzinger, B Martinez de Tejada, C Marzolini, K J Metzner, N Müller, J Nemeth, D Nicca, J Notter, P Paioni, G Pantaleo, M Perreau, A Rauch, L P Salazar-Vizcaya, P Schmid, O Segeral, R F Speck, M Stöckle, B Surial, P E Tarr, A Trkola, G Wandeler, M Weisser, S Yerly
DOI
2026
A Randomized, Double-Blind Clinical Trial of One vs. Two Doses of High-Dose Influenza Vaccine in Solid Organ Transplant Recipients
Kevin Escandón-Vargas, Sophia Q Tang, Jamie Forschmiedt, Kwang Low, Bob C. Lin, Jenny Lu Wang, Mike Castro, S. Narpala, Leonid Serebryannyy, Jodi Anderson, Jarrett Reichel, Richard A. Koup, Kyle D Rudser, Hareesh v Singam, Joshua Rhein, Susan Kline, Timothy W. Schacker, Lauren Fontana
DOI Abstract
45
Overall
Below Average
31
35
30
40
36
85
0
0
0
0
0
Journament

Overall Quality Score

44.7/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.1/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

36.0/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

85.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.